Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium.

Journal: Urologic oncology
Published Date: Nov 15, 2019

Abstract

PURPOSE: Several guidelines recommend pelvic lymph node dissection (PLND) at robot-assisted radical prostatectomy (RARP) only when lymph node involvement (LN+) is >2%. Individual surgeon use of PLND is not well-known. We sought to examine variability in PLND performance and detection of LN+ across the Michigan Urological Surgery Improvement Collaborative.

Authors

  • Hernan Lescay
    Divison of Urology, Spectrum Health Hospital System, Grand Rapids, MI; Central Michigan University College of Medicine, Mt. Pleasant, MI.
  • Firas Abdollah
    Vattikuti Urology Institute, Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, Detroit, MI, USA.
  • Michael L Cher
    Division of Urology, Wayne State University, Detroit, MI.
  • Ji Qi
    Institute of Advanced Research, Infervision Medical Technology Co., Ltd, Beijing, China.
  • Susan Linsell
    Department of Urology, University of Michigan, Ann Arbor, MI.
  • David C Miller
  • James E Montie
    Department of Urology, University of Michigan, Ann Arbor, MI.
  • James Peabody
    Vattikuti Urology Institute and VUI Center for Outcomes Research Analytics and Evaluation (VCORE), Henry Ford Hospital, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202-2689, USA.
  • Samuel Kaffenberger
    Department of Urology, University of Michigan, Ann Arbor, MI.
  • Todd Morgan
    Department of Urology, University of Michigan, Ann Arbor, MI.
  • Aram Loeb
    Division of Urology, Wayne State University, Detroit, MI.
  • Brian R Lane
    Spectrum Health, Grand Rapids, MI, USA. brian.lane@spectrumhealth.org.

Keywords

External Resources

Popular Topics
Recent Journals